Key result
FK506 is linked to QT prolongation and Torsades de Pointes.
Why the study?
Does FK506 administration cause QT prolongation and Torsades de Pointes?
Comparison
FK506 administration
Design
Case report
Authors
Loading...
Early pediatric transplant experience with triple therapy leaves open questions on long-term coronary risk; larger prospective studies needed.
Case Report
Does FK506 administration cause QT prolongation and Torsades de Pointes?
Administration of FK506 may be associated with QT prolongation and Torsades de Pointes.
Johnson et al. (1992) conducted a case report in QT prolongation and Torsades de Pointes. FK506 was evaluated on QT prolongation and Torsades de Pointes. Administration of FK506 was associated with QT prolongation and Torsades de Pointes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: